Convey Holding Parent, Inc. (NYSE: CNVY) has successfully completed its initial public offering, selling 13,333,334 shares at $14.00 each. The offering consisted of 11,666,667 shares sold by the company and 1,666,667 shares by a selling stockholder. Additionally, underwriters have a 30-day option to buy up to 2,000,000 additional shares. The registration statement for this sale was declared effective on June 15, 2021. BofA Securities, Goldman Sachs, and J.P. Morgan were the lead underwriters for this offering.
Convey Holding Parent, Inc. has announced the pricing of its initial public offering (IPO) of 13,333,334 shares at $14.00 each, with the offering expected to close on June 18, 2021. The IPO includes 11,666,667 shares from the company and 1,666,667 from a selling stockholder. The underwriters hold a 30-day option for 2,000,000 additional shares. The company's stock will begin trading on the NYSE under the ticker symbol 'CNVY' on June 16, 2021. Proceeds will be used to repay existing debt and for general corporate purposes.
Convey Health announced the launch of its initial public offering (IPO) of 13,333,334 shares of common stock, aiming to offer 11,666,667 shares by the company and 1,666,667 shares from a selling stockholder. The IPO price is estimated between $14.00 and $16.00 per share, with an option for underwriters to purchase an additional 2,000,000 shares. Proceeds will be used to repay existing debt and for general corporate purposes. Convey Health seeks to list on the New York Stock Exchange under the ticker CNVY.